Literature DB >> 8319206

Modeling the development of metastases from primary and locally recurrent tumors: comparison with a clinical data base for prostatic cancer.

E D Yorke1, Z Fuks, L Norton, W Whitmore, C C Ling.   

Abstract

For many types of cancer, patients who relapse locally following localized treatment such as surgery or radiation therapy are found to have a higher incidence of distant metastases than those who are locally controlled. In this study we developed a mathematical model to investigate whether the excess distant metastases arise mainly from the local recurrence or whether the primary tumors in this group of patients have an intrinsically higher metastatic potential than those of locally controlled patients of the same clinical stage. The parameters of the model were chosen to be representative of prostate cancer and the calculated results were compared with published clinical data for carcinoma of the prostate. The best agreement with the data was seen for parameters which imply somewhat more "aggressive" primary tumors for locally relapsing patients, yielding relatively high rates of micrometastatic dissemination prior to initial diagnosis. However, the model calculations indicate that more than half of the metastases in such patients originated in association with the development of a local recurrence. Therefore, achieving local control in this group of patients would be beneficial in improving long term survival.

Entities:  

Mesh:

Year:  1993        PMID: 8319206

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

1.  The impact of dose on parotid salivary recovery in head and neck cancer patients treated with radiation therapy.

Authors:  Yun Li; Jeremy M G Taylor; Randall K Ten Haken; Avraham Eisbruch
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-12-04       Impact factor: 7.038

Review 2.  Role of magnetic resonance imaging and magnetic resonance spectroscopic imaging before and after radiotherapy for prostate cancer.

Authors:  Antonio C Westphalen; David A McKenna; John Kurhanewicz; Fergus V Coakley
Journal:  J Endourol       Date:  2008-04       Impact factor: 2.942

3.  Therapeutic Enzyme-Responsive Nanoparticles for Targeted Delivery and Accumulation in Tumors.

Authors:  Cassandra E Callmann; Christopher V Barback; Matthew P Thompson; David J Hall; Robert F Mattrey; Nathan C Gianneschi
Journal:  Adv Mater       Date:  2015-07-14       Impact factor: 30.849

4.  Modeling Spontaneous Metastasis following Surgery: An In Vivo-In Silico Approach.

Authors:  Sebastien Benzekry; Amanda Tracz; Michalis Mastri; Ryan Corbelli; Dominique Barbolosi; John M L Ebos
Journal:  Cancer Res       Date:  2015-10-28       Impact factor: 12.701

5.  Modeling the connection between primary and metastatic tumors.

Authors:  David Diego; Gabriel F Calvo; Víctor M Pérez-García
Journal:  J Math Biol       Date:  2012-07-25       Impact factor: 2.259

Review 6.  Array of translational systems pharmacodynamic models of anti-cancer drugs.

Authors:  Sihem Ait-Oudhia; Donald E Mager
Journal:  J Pharmacokinet Pharmacodyn       Date:  2016-10-22       Impact factor: 2.745

7.  Prostate cancer: role of pretreatment MR in predicting outcome after external-beam radiation therapy--initial experience.

Authors:  David A McKenna; Fergus V Coakley; Antonio C Westphalen; Shoujun Zhao; Ying Lu; Emily M Webb; Barby Pickett; Mack Roach; John Kurhanewicz
Journal:  Radiology       Date:  2008-02-07       Impact factor: 11.105

8.  Numerical modeling of nanodrug distribution in tumors with heterogeneous vasculature.

Authors:  Cheng-Ying Chou; Wan-I Chang; Tzyy-Leng Horng; Win-Li Lin
Journal:  PLoS One       Date:  2017-12-29       Impact factor: 3.240

9.  A new concept for cancer therapy: out-competing the aggressor.

Authors:  Thomas S Deisboeck; Zhihui Wang
Journal:  Cancer Cell Int       Date:  2008-12-12       Impact factor: 5.722

10.  Enhanced Drug Delivery to Solid Tumors via Drug-Loaded Nanocarriers: An Image-Based Computational Framework.

Authors:  Farshad Moradi Kashkooli; M Soltani; Mohammad Masoud Momeni; Arman Rahmim
Journal:  Front Oncol       Date:  2021-06-24       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.